Morgan Stanley’s Natural Health Trends NHTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $46 | Buy |
26
+8
| +44% | +$21 | ﹤0.01% | 8124 |
|
|
2026
Q1 | $50 | Buy |
18
+1
| +6% | +$3 | ﹤0.01% | 7954 |
|
|
2025
Q4 | $53 | Sell |
17
-1,001
| -98% | -$3.63K | ﹤0.01% | 7835 |
|
|
2025
Q3 | $4.56K | Sell |
1,018
-238
| -19% | -$1.08K | ﹤0.01% | 7116 |
|
|
2025
Q2 | $5.44K | Buy |
1,256
+501
| +66% | +$2.4K | ﹤0.01% | 7012 |
|
|
2025
Q1 | $3.82K | Sell |
755
-104
| -12% | -$517 | ﹤0.01% | 7051 |
|
|
2024
Q4 | $3.97K | Sell |
859
-154
| -15% | -$836 | ﹤0.01% | 7065 |
|
|
2024
Q3 | $6.03K | Buy |
1,013
+1
| +0.1% | +$7 | ﹤0.01% | 6856 |
|
|
2024
Q2 | $7.19K | Buy |
1,012
+146
| +17% | +$999 | ﹤0.01% | 6768 |
|
|
2024
Q1 | $5.8K | Sell |
866
-848
| -49% | -$5.29K | ﹤0.01% | 6856 |
|
|
2023
Q4 | $10K | Buy |
1,714
+457
| +36% | +$2.51K | ﹤0.01% | 6835 |
|
|
2023
Q3 | $6.66K | Sell |
1,257
-100
| -7% | -$544 | ﹤0.01% | 6847 |
|
|
2023
Q2 | $7.5K | Sell |
1,357
-3,199
| -70% | -$17.5K | ﹤0.01% | 6900 |
|
|
2023
Q1 | $22.5K | Sell |
4,556
-841
| -16% | -$4.16K | ﹤0.01% | 6579 |
|
|
2022
Q4 | $18.5K | Buy |
5,397
+2,420
| +81% | +$9.21K | ﹤0.01% | 6723 |
|
|
2022
Q3 | $11K | Sell |
2,977
-5,673
| -66% | -$28.6K | ﹤0.01% | 7042 |
|
|
2022
Q2 | $46K | Sell |
8,650
-11,422
| -57% | -$75.8K | ﹤0.01% | 6650 |
|
|
2022
Q1 | $142K | Buy |
20,072
+1,516
| +8% | +$11K | ﹤0.01% | 6108 |
|
|
2021
Q4 | $125K | Sell |
18,556
-358
| -2% | -$2.56K | ﹤0.01% | 6308 |
|
|
2021
Q3 | $136K | Buy |
18,914
+1,776
| +10% | +$12.4K | ﹤0.01% | 6198 |
|
|
2021
Q2 | $120K | Sell |
17,138
-1,034
| -6% | -$7.48K | ﹤0.01% | 6272 |
|
|
2021
Q1 | $122K | Sell |
18,172
-6,335
| -26% | -$40.5K | ﹤0.01% | 5907 |
|
|
2020
Q4 | $122K | Sell |
24,507
-7,734
| -24% | -$43K | ﹤0.01% | 5825 |
|
|
2020
Q3 | $182K | Sell |
32,241
-5,553
| -15% | -$31.8K | ﹤0.01% | 5165 |
|
|
2020
Q2 | $216K | Buy |
37,794
+998
| +3% | +$5.16K | ﹤0.01% | 5044 |
|
|
2020
Q1 | $121K | Sell |
36,796
-2,994
| -8% | -$12.1K | ﹤0.01% | 5104 |
|
|
2019
Q4 | $215K | Sell |
39,790
-17,643
| -31% | -$113K | ﹤0.01% | 5381 |
|
|
2019
Q3 | $407K | Sell |
57,433
-276,862
| -83% | -$2.03M | ﹤0.01% | 4785 |
|
|
2019
Q2 | $2.69M | Buy |
334,295
+249,065
| +292% | +$2.6M | ﹤0.01% | 3530 |
|
|
2019
Q1 | $1.1M | Buy |
85,230
+59,932
| +237% | +$894K | ﹤0.01% | 4041 |
|
|
2018
Q4 | $468K | Buy |
25,298
+10,957
| +76% | +$241K | ﹤0.01% | 4829 |
|
|
2018
Q3 | $333K | Sell |
14,341
-24,823
| -63% | -$608K | ﹤0.01% | 5215 |
|
|
2018
Q2 | $980K | Sell |
39,164
-4,413
| -10% | -$92.3K | ﹤0.01% | 4645 |
|
|
2018
Q1 | $828K | Sell |
43,577
-59,709
| -58% | -$1.01M | ﹤0.01% | 4687 |
|
|
2017
Q4 | $1.57M | Buy |
103,286
+48,496
| +89% | +$914K | ﹤0.01% | 4227 |
|
|
2017
Q3 | $1.31M | Buy |
54,790
+12,297
| +29% | +$281K | ﹤0.01% | 4248 |
|
|
2017
Q2 | $1.18M | Buy |
42,493
+21,572
| +103% | +$616K | ﹤0.01% | 4249 |
|
|
2017
Q1 | $605K | Sell |
20,921
-4,524
| -18% | -$122K | ﹤0.01% | 4720 |
|
|
2016
Q4 | $632K | Buy |
25,445
+22,986
| +935% | +$579K | ﹤0.01% | 4776 |
|
|
2016
Q3 | $69K | Buy |
2,459
+879
| +56% | +$27.2K | ﹤0.01% | 5461 |
|
|
2016
Q2 | $45K | Sell |
1,580
-2,363
| -60% | -$77.2K | ﹤0.01% | 5565 |
|
|
2016
Q1 | $131K | Sell |
3,943
-98,691
| -96% | -$2.68M | ﹤0.01% | 5189 |
|
|
2015
Q4 | $3.44M | Buy |
102,634
+59,868
| +140% | +$2.64M | ﹤0.01% | 3028 |
|
|
2015
Q3 | $1.4M | Buy |
42,766
+13,112
| +44% | +$397K | ﹤0.01% | 3824 |
|
|
2015
Q2 | $1.23M | Buy |
29,654
+1,224
| +4% | +$36.3K | ﹤0.01% | 4046 |
|
|
2015
Q1 | $509K | Buy |
+28,430
| New | +$449K | ﹤0.01% | 4642 |
|
Other funds holding NHTC
BCM
Morgan Stanley's NHTC Position: Q2 2026 in Review
Morgan Stanley increased its Natural Health Trends (NHTC) stake by 44% in Q2 2026, buying an estimated $21 and bringing the position to 26 shares worth $46. The position accounts for ﹤0.01% of the portfolio, ranked #8124.
Morgan Stanley first reported a position in NHTC in Q1 2015 and has held it in 46 quarters since. The position peaked at $3.44M in Q4 2015. 22 funds tracked by Wall St. Rank hold NHTC as of Q2 2026.
- Morgan Stanley held 26 shares of Natural Health Trends worth $46 as of Q2 2026.
- Morgan Stanley bought 8 Natural Health Trends shares in Q2 2026, an estimated $21.
- Natural Health Trends made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #8124 holding.
- Morgan Stanley first reported a position in Natural Health Trends in Q1 2015 and has held it in 46 quarters since.
- Morgan Stanley's Natural Health Trends position peaked at $3.44M in Q4 2015.
- 22 funds tracked by Wall St. Rank held Natural Health Trends as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.